Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' WOLF CR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 151 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ding, S; Yao, D; Deeni, YY; Burchell, B; Wolf, CR; Friedberg, T
      Human NADPH-P450 oxidoreductase modulates the level of cytochrome P450CYP2D6 holoprotein via haem oxygenase-dependent and -independent pathways

      BIOCHEMICAL JOURNAL
    2. Kim, H; Putt, DA; Zangar, RC; Wolf, CR; Guengerich, FP; Edwards, RJ; Hollenberg, PF; Novak, RF
      Differential induction of rat hepatic cytochromes P450 3A1, 3A2, 2B1, 2B2,and 2E1 in response to pyridine treatment

      DRUG METABOLISM AND DISPOSITION
    3. Wolf, CR
      Chemoprevention: Increased potential to bear fruit

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    4. Dohr, O; Paine, MJI; Friedberg, T; Roberts, GCK; Wolf, CR
      Engineering of a functional human NADH-dependent cytochrome P450 system

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    5. Ruscoe, JE; Rosario, LA; Wang, TL; Gate, L; Arifoglu, P; Wolf, CR; Henderson, CJ; Ronai, Z; Tew, KD
      Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GST pi) influences cell proliferation pathways

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    6. Baron, JM; Goh, LB; Yao, DG; Wolf, CR; Friedberg, T
      Modulation of P450CYP3A4-dependent metabolism by P-glycoprotein: Implications for P450 phenotyping

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    7. Vosper, H; Patel, L; Graham, TL; Khoudoli, GA; Hill, A; Macphee, CH; Pinto, I; Smith, SA; Suckling, KE; Wolf, CR; Palmer, CNA
      The peroxisome proliferator-activated receptor delta promotes lipid accumulation in human macrophages

      JOURNAL OF BIOLOGICAL CHEMISTRY
    8. Finnstrom, N; Bjelfman, C; Soderstrom, TG; Smith, G; Egevad, L; Norlen, BJ; Wolf, CR; Rane, A
      Detection of cytochrome P450 mRNA transcripts in prostate samples by RT-PCR

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    9. Wolf, CR; Park, BK; Kitteringham, N; Otto, D; Henderson, CH
      Functional and genetic analysis of glutathione S-transferase pi

      CHEMICO-BIOLOGICAL INTERACTIONS
    10. McMaghon, M; Chanas, SA; Henderson, CJ; Wolf, CR; Yamamoto, M; Hayes, JD
      The Nrf2 transcription factor regulates basal expression of class Alpha and class Mu glutathione S-transferases in the mouse, but not necessarily their induction by cancer chemopreventive agents

      CHEMICO-BIOLOGICAL INTERACTIONS
    11. McMahon, M; Itoh, K; Yamamoto, M; Chanas, SA; Henderson, CJ; McLellan, LI; Wolf, CR; Cavin, C; Hayes, JD
      The cap 'n' collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression ofintestinal detoxification and glutathione biosynthetic enzymes

      CANCER RESEARCH
    12. Ding, S; Chamberlain, M; McLaren, A; Goh, LB; Duncan, I; Wolf, CR
      Cross-talk between signalling pathways and the multidrug resistant proteinMDR-1

      BRITISH JOURNAL OF CANCER
    13. Gutierrez, A; Lian, LY; Wolf, CR; Scrutton, NS; Roberts, GCK
      Stopped-flow kinetic studies of flavin reduction in human cytochrome P450 reductase and its component domains

      BIOCHEMISTRY
    14. Paine, MJI; Ayivor, S; Munro, A; Tsan, P; Lian, LY; Roberts, GCK; Wolf, CR
      Role of the conserved phenylalanine 181 of NADPH-cytochrome p450 oxidoreductase in FMN binding and catalytic activity

      BIOCHEMISTRY
    15. Deeni, YY; Paine, MJI; Ayrton, AD; Clarke, SE; Chenery, R; Wolf, CR
      Expression, purification, and biochemical characterization of a human cytochrome P450CYP2D6-NADPH cytochrome P450 reductase fusion protein

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    16. Li, DN; Seidel, A; Pritchard, MP; Wolf, CR; Friedberg, T
      Polymorphisms in P450CYP1B1 affect the conversion of estradiol to the potentially carcinogenic metabolite 4-hydroxyestradiol

      PHARMACOGENETICS
    17. Wolf, CR; Smith, G; Smith, RL
      Science, medicine, and the future - Pharmacogenetics

      BRITISH MEDICAL JOURNAL
    18. Hayes, JD; Chanas, SA; Henderson, CJ; McMahon, M; Sun, C; Moffat, GJ; Wolf, CR; Yamamoto, M
      The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin

      BIOCHEMICAL SOCIETY TRANSACTIONS
    19. Henderson, CJ; Sahraouei, A; Wolf, CR
      Cytochrome P450s and chemoprevention

      BIOCHEMICAL SOCIETY TRANSACTIONS
    20. Ellis, SW; Hayhurst, GP; Lightfoot, T; Smith, G; Harlow, J; Rowland-Yeo, K; Larsson, C; Mahling, J; Lim, CK; Wolf, CR; Blackburn, MG; Lennard, MS; Tucker, GT
      Evidence that serine 304 is not a key ligand-binding residue in the activesite of cytochrome P450 2D6

      BIOCHEMICAL JOURNAL
    21. Henderson, CJ; Wolf, CR; Kitteringham, N; Powell, H; Otto, D; Park, BK
      Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase Pi

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    22. Rosario, LA; O'Brien, ML; Henderson, CJ; Wolf, CR; Tew, KD
      Cellular response to a glutathione S-transferase P1-1 activated prodrug

      MOLECULAR PHARMACOLOGY
    23. Yao, DG; Ding, SH; Burchell, B; Wolf, CR; Friedberg, T
      Detoxication of vinca alkaloids by human P450CYP3A4-mediated metabolism: Implications for the development of drug resistance

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    24. Paine, MJI; Garner, AP; Powell, D; Sibbald, J; Sales, M; Pratt, N; Smith, T; Tew, DG; Wolf, CR
      Cloning and characterization of a novel human dual flavin reductase

      JOURNAL OF BIOLOGICAL CHEMISTRY
    25. Gutierrez, A; Doehr, O; Paine, M; Wolf, CR; Scrutton, NS; Roberts, GCK
      Trp-676 facilitates nicotinamide coenzyme exchange in the reductive half-reaction of human cytochrome P450 reductase: Properties of the soluble W676Rand W676A mutant reductases

      BIOCHEMISTRY
    26. Fowler, SM; Riley, RJ; Pritchard, MP; Sutcliffe, MJ; Friedberg, T; Wolf, CR
      Amino acid 305 determines catalytic center accessibility in CYP3A4

      BIOCHEMISTRY
    27. Pawlowska, J; Tarasiuk, J; Borowski, E; Wasowska, M; Oszczapowicz, I; Wolf, CR
      The ability of new formamidine sugar-modified derivatives of daunorubicin to stimulate free radical formation in three enzymatic systems: NADH dehydrogenase, NADPH cytochrome P450 reductase and xanthine oxidase

      ACTA BIOCHIMICA POLONICA
    28. McLellan, LI; Wolf, CR
      Glutathione and glutathione-dependent enzymes in cancer drug resistance

      DRUG RESISTANCE UPDATES
    29. Zhao, Q; Modi, S; Smith, G; Paine, M; McDonagh, PD; Wolf, CR; Tew, D; Lian, LY; Roberts, GCK; Driessen, HPC
      Crystal structure of the FMN-binding domain of human cytochrome P450 reductase at 1.93 angstrom resolution

      PROTEIN SCIENCE
    30. Wadelius, M; Autrup, JL; Stubbins, MJ; Andersson, SO; Johansson, JE; Wadelius, C; Wolf, CR; Autrup, H; Rane, A
      Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer

      PHARMACOGENETICS
    31. Friedberg, T; Pritchard, MP; Bandera, M; Hanlon, SP; Yao, D; McLaughlin, LA; Ding, S; Burchell, B; Wolf, CR
      Merits and limitations of recombinant models for the study of human P450-mediated drug metabolism and toxicity: An intralaboratory comparison

      DRUG METABOLISM REVIEWS
    32. Palmer, CNA; Gustafsson, MCU; Dobson, H; von Wachenfeldt, C; Wolf, CR
      Adaptive responses to fatty acids are mediated by the regulated expressionof cytochromes P450

      BIOCHEMICAL SOCIETY TRANSACTIONS
    33. Allardyce, CS; McDonagh, PD; Lian, LY; Wolf, CR; Roberts, GCK
      The role of tyrosine-9 and the C-terminal helix in the catalytic mechanismof Alpha-class glutathione S-transferases

      BIOCHEMICAL JOURNAL
    34. McDonagh, PD; Judah, DJ; Hayes, JD; Lian, LY; Neal, GE; Wolf, CR; Roberts, GCK
      Determinants of specificity for aflatoxin B-1-8,9-epoxide in Alpha-class glutathione S-transferases

      BIOCHEMICAL JOURNAL
    35. Adler, V; Yin, ZM; Fuchs, SY; Benezra, M; Rosario, L; Tew, KD; Pincus, MR; Sardana, M; Henderson, CJ; Wolf, CR; Davis, RJ; Ronai, Z
      Regulation of JNK signaling by GSTp

      EMBO JOURNAL
    36. Lechevrel, M; Casson, AG; Wolf, CR; Hardie, LJ; Flinterman, MB; Montesano, R; Wild, CP
      Characterization of cytochrome P450 expression in human oesophageal mucosa

      CARCINOGENESIS
    37. Li, DN; Pritchard, MP; Hanlon, SP; Burchell, B; Wolf, CR; Friedberg, T
      Competition between cytochrome P-450 isozymes for NADPH-cytochrome P-450 oxidoreductase affects drug metabolism

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    38. McLaughlin, L; Burchell, B; Pritchard, M; Wolf, CR; Friedberg, T
      Treatment of mammalian cells with the endoplasmic reticulum-proliferator compactin strongly induces recombinant and endogenous xenobiotic metabolizing enzymes and 3-hydroxy-3-methylglutaryl-CoA reductase in vitro

      JOURNAL OF CELL SCIENCE
    39. Causevic, M; Wolf, CR; Palmer, CNA
      Substitution of a conserved amino acid residue alters the ligand binding properties of peroxisome proliferator activated receptors

      FEBS LETTERS
    40. Garner, AP; Paine, MJI; Rodriguez-Crespo, I; Chinje, EC; De Montellano, PO; Stratford, IJ; Tew, DG; Wolf, CR
      Nitric oxide synthases catalyze the activation of redox cycling and bioreductive anticancer agents

      CANCER RESEARCH
    41. Wolf, CR; Smith, G
      Pharmacogenetics

      BRITISH MEDICAL BULLETIN
    42. Voice, MW; Zhang, Y; Wolf, CR; Burchell, B; Friedberg, T
      Effects of human cytochrome b(5) on CYP3A4 activity and stability in vivo

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    43. Friedberg, T; Henderson, CJ; Pritchard, MP; Wolf, CR
      In vivo and in vitro recombinant DNA technology as a powerful tool in drugdevelopment

      HANDBOOK OF DRUG METABOLISM
    44. WORRALL SF; CORRIGAN M; HIGH A; STARR D; MATTHIAS C; WOLF CR; JONES PW; HAND P; GILFORD J; FARRELL WE; HOBAN P; FRYER AA; STRANGE RC
      SUSCEPTIBILITY AND OUTCOME IN ORAL-CANCER - PRELIMINARY DATA SHOWING AN ASSOCIATION WITH POLYMORPHISM IN CYTOCHROME-P450 CYP2D6

      Pharmacogenetics
    45. MATTHIAS C; BOCKMUHL U; JAHNKE V; HARRIES LW; WOLF CR; JONES PW; ALLDERSEA J; WORRALL SF; HAND P; FRYER AA; STRANGE RC
      THE GLUTATHIONE-S-TRANSFERASE GSTP1 POLYMORPHISM - EFFECTS ON SUSCEPTIBILITY TO ORAL PHARYNGEAL AND LARYNGEAL CARCINOMAS/

      Pharmacogenetics
    46. PRITCHARD MP; GLANCEY MJ; BLAKE JAR; GILHAM DE; BURCHELL B; WOLF CR; FRIDBERG T
      FUNCTIONAL COEXPRESSION OF CYP2D6 AND HUMAN NADPH-CYTOCHROME P450 REDUCTASE IN ESCHERICHIA-COLI

      Pharmacogenetics
    47. Spurr, NK; Autrup, H; Bishop, T; Haugen, A; Lang, M; Lafuente, A; Lechner, MC; Lucotte, G; Rane, A; Regateiro, FJ; Strange, RC; Wolf, CR
      Metabolic polymorphism of drug metabolising enzymes as markers of susceptibility in cancer and neurological disorders

      CANCER RESEARCH SUPPORTED UNDER BIOMED I
    48. SMITH G; MODI S; PILLAI I; LIAN LY; SUTCLIFFE MJ; PRITCHARD MP; FRIEDBERG T; ROBERTS GCK; WOLF CR
      DETERMINANTS OF THE SUBSTRATE-SPECIFICITY OF HUMAN CYTOCHROME-P-450 CYP2D6 - DESIGN AND CONSTRUCTION OF A MUTANT WITH TESTOSTERONE HYDROXYLASE-ACTIVITY

      Biochemical journal
    49. Smith, G; Stubbins, MJ; Harries, LW; Wolf, CR
      Molecular genetics of the human cytochrome P450 monooxygenase superfamily

      XENOBIOTICA
    50. WOLF CR; PALMER CNA
      MECHANISMS OF GENE-REGULATION BY FATTY-ACIDS AND BARBITURATE DRUGS

      Naunyn-Schmiedeberg's archives of pharmacology
    51. FRIEDBERG T; DING SH; BURCHELL B; WOLF CR; YAO DG
      CYTOCHROME P450S MEDIATE A NOVEL PATHWAY OF DRUG-RESISTANCE TO CYTOSTATIC COMPOUNDS

      Naunyn-Schmiedeberg's archives of pharmacology
    52. HENDERSON CJ; SMITH AG; URE J; BROWN K; BACON EJ; WOLF CR
      INCREASED SKIN TUMORIGENESIS IN MICE LACKING PI CLASS GLUTATHIONE S-TRANSFERASES

      Proceedings of the National Academy of Sciences of the United Statesof America
    53. Wolf, CR; Henderson, CJ
      Use of transgenic animals in understanding molecular mechanisms of toxicity

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    54. PALMER CNA; AXEN E; HUGHES V; WOLF CR
      THE REPRESSOR PROTEIN, BM3R1, MEDIATES AN ADAPTIVE RESPONSE TO TOXIC FATTY-ACIDS IN BACILLUS-MEGATERIUM

      The Journal of biological chemistry
    55. PALMER CNA; WOLF CR
      CIS-PARINARIC ACID IS A LIGAND FOR THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-GAMMA - DEVELOPMENT OF A NOVEL SPECTROPHOTOMETRIC ASSAY FOR THE DISCOVERY OF PPAR-GAMMA LIGANDS

      FEBS letters
    56. OESCHBARTLOMOWICZ B; PADMA PR; BECKER R; RICHTER B; HENGSTLER JG; FREEMAN JE; WOLF CR; OESCH F
      DIFFERENTIAL MODULATION OF CYP2E1 ACTIVITY BY CAMP-DEPENDENT PROTEIN-KINASE UPON SER(129) REPLACEMENT

      Experimental cell research
    57. HENDERSON CJ; MCLAREN AW; MOFFAT GJ; BACON EJ; WOLF CR
      PI-CLASS GLUTATHIONE-S-TRANSFERASE - REGULATION AND FUNCTION

      Chemico-biological interactions
    58. ROBERTS GCK; MODI S; SUTCLIFFE MJ; LIAN LY; PRIMROSE WU; WOLF CR
      THE USE OF NMR METHODS TO STUDY SUBSTRATE-BINDING TO CYTOCHROMES P450

      British Journal of Pharmacology
    59. HOPKINS NE; ENGLISH N; HUGHES V; ROWLEY CW; WOLF CR; ALWORTH WL
      INDUCTION OF CYP102 (CYTOCHROME-P450(BM-3)) IN BACILLUS-MEGATERIUM BY17-BETA-ESTRADIOL AND 4-SEC-BUTYLPHENOL (VOL 244, PG 868, 1998)

      Biochemical and biophysical research communications
    60. HOPKINS NE; ENGLISH N; HUGHES V; ROWLEY CW; WOLF CR; ALWORTH WL
      INDUCTION OF CYP102 (CYTOCHROME P450(BM-3)) IN BACILLUS-MEGATERIUM BY17-BETA-ESTRADIOL AND 4-SEC-BUTYLPHENOL

      Biochemical and biophysical research communications
    61. BARSUKOV I; MODI S; LIAN LY; SZE KH; PAINE MJI; WOLF CR; ROBERTS GCK
      H-1,N-15 AND C-13 NMR RESONANCE ASSIGNMENT, SECONDARY STRUCTURE AND GLOBAL FOLD OF THE FMN-BINDING DOMAIN OF HUMAN CYTOCHROME-P450 REDUCTASE

      Journal of biomolecular NMR
    62. MODI S; PAINE MJ; OLIVER CF; SMITH G; SUTCLIFFE MJ; GILHAM DE; SHAW ANJ; LIAN LY; PRIMROSE WU; WOLF CR; ROBERTS GCK
      ACTIVE-SITE MODELS OF HUMAN CYTOCHROME P450S BASED ON NMR RELAXATION MEASUREMENTS

      The FASEB journal
    63. WOLF CR; MODI S; LIAN LY; PAINE M; SMITH G; ROBERTS GCK
      GENETIC STRUCTURAL AND FUNCTIONAL-ANALYSIS OF CYTOCHROME P450S IN THECYP2D GENE FAMILY

      The FASEB journal
    64. ROBERTS GCK; SUTCLIFFE MJ; MODI S; LIAN LY; PRIMROSE WU; WOLF CR
      CONSTRUCTION OF MODELS OF P450-SUBSTRATE COMPLEXES BY A COMBINATION OF NMR AND HOMOLOGY MODELING

      The FASEB journal
    65. ROBERTS GCK; MODI S; GILHAM DE; SUTCLIFFE MJ; LIAN LY; PRIMROSE WU; WOLF CR
      ALLOSTERIC EFFECTS OF CYTOCHROME-P450 REDUCTASE ON CYTOCHROME-P450 2D6

      The FASEB journal
    66. PALMER CNA; CAUSEVIC M; WOLF CR
      MODULATION OF FATTY-ACID SIGNALING BY CYTOCHROME P-450-MEDIATED HYDROXYLATION

      Biochemical Society transactions
    67. ENGLISH N; PALMER CNA; ALWORTH WL; KANG L; HUGHES V; WOLF CR
      FATTY-ACID SIGNALS IN BACILLUS-MEGATERIUM ARE ATTENUATED BY CYTOCHROME P-450-MEDIATED HYDROXYLATION

      Biochemical journal
    68. RYBERG D; SKAUG V; HEWER A; PHILLIPS DH; HARRIES LW; WOLF CR; OGREID D; ULVIK A; VU P; HAUGEN A
      GENOTYPES OF GLUTATHIONE TRANSFERASE M1 AND P1 AND THEIR SIGNIFICANCEFOR LUNG DNA ADDUCT LEVELS AND CANCER RISK

      Carcinogenesis
    69. HARRIES LW; STUBBINS MJ; FORMAN D; HOWARD GCW; WOLF CR
      IDENTIFICATION OF GENETIC POLYMORPHISMS AT THE GLUTATHIONE-S-TRANSFERASE-PI LOCUS AND ASSOCIATION WITH SUSCEPTIBILITY TO BLADDER, TESTICULAR AND PROSTATE-CANCER

      Carcinogenesis
    70. PATEL HRH; HEWER A; PHILLIPS DH; HAYES JD; WOLF CR; CAMPBELL FC
      METABOLIC COMPETENCE AND SUSCEPTIBILITY OF INTESTINAL EPITHELIUM TO GENOTOXIC INJURY DURING REGENERATION

      Carcinogenesis
    71. GILHAM DE; CAIRNS W; PAINE MJI; MODI S; POULSOM R; ROBERTS GCK; WOLF CR
      METABOLISM OF MPTP BY CYTOCHROME P4502D6 AND THE DEMONSTRATION OF 2D6MESSENGER-RNA IN HUMAN FETAL AND ADULT BRAIN BY IN-SITU HYBRIDIZATION

      Xenobiotica
    72. PRITCHARD M; KUSIAK M; HANLON S; VOICE M; ROBERTS J; BURCHELL B; WOLF CR; FRIEDBERG T
      BACTERIAL EXPRESSION OF FUNCTIONAL HUMAN P450 MONOOXYGENASE SYSTEMS FOR DRUG DEVELOPMENT

      Naunyn-Schmiedeberg's archives of pharmacology
    73. SMITH CAD; WADELIUS M; GOUGH AC; HARRISON DJ; WOLF CR; RANE A
      A SIMPLIFIED ASSAY FOR THE ARYLAMINE N-ACETYLTRANSFERASE-2 POLYMORPHISM VALIDATED BY PHENOTYPING WITH ISONIAZID

      Journal of Medical Genetics
    74. PEDDIE CM; WOLF CR; MCLELLAN LI; COLLINS AR; BOWEN DT
      OXIDATIVE DNA-DAMAGE IN CD34(-NECROSIS-FACTOR-ALPHA CONCENTRATION() MYELODYSPLASTIC CELLS IS ASSOCIATED WITH INTRACELLULAR REDOX CHANGES AND ELEVATED PLASMA TUMOR)

      British Journal of Haematology
    75. VALLIS KA; REGLINSKI J; GARNER M; BRIDGEMAN MME; WOLF CR
      MENADIONE-RESISTANT CHINESE-HAMSTER OVARY CELLS HAVE AN INCREASED CAPACITY FOR GLUTATHIONE SYNTHESIS

      British Journal of Cancer
    76. BOWEN DT; PEDDIE CM; COLLINS AR; WOLF CR
      PYRIMIDINE NUCLEOTIDE OXIDATION IN CD34-NECROSIS-FACTOR-ALPHA( MYELODYSPLASTIC CELLS IS ASSOCIATED WITH ALTERED INTRACELLULAR REDOX AND ELEVATED PLASMA TUMOR)

      Blood
    77. MODI S; GILHAM DE; SUTCLIFFE MJ; LIAN LY; PRIMROSE WU; WOLF CR; ROBERTS GCK
      1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE AS A SUBSTRATE OF CYTOCHROME-P450 2D6 - ALLOSTERIC EFFECTS OF NADPH-CYTOCHROME P450 REDUCTASE

      Biochemistry
    78. DING SH; YAO DG; BURCHELL B; WOLF CR; FRIEDBERG T
      HIGH-LEVELS OF RECOMBINANT CYP3A4 EXPRESSION IN CHINESE-HAMSTER OVARYCELLS ARE MODULATED BY COEXPRESSED HUMAN P450 REDUCTASE AND HEMIN SUPPLEMENTATION

      Archives of biochemistry and biophysics
    79. PRITCHARD MP; OSSETIAN R; LI DN; HENDERSON CJ; BURCHELL B; WOLF CR; FRIEDBERG T
      A GENERAL STRATEGY FOR THE EXPRESSION OF RECOMBINANT HUMAN CYTOCHROMEP450S IN ESCHERICHIA-COLI USING BACTERIAL SIGNAL PEPTIDES - EXPRESSION OF CYP3A4, CYP2A6, AND CYP2E1

      Archives of biochemistry and biophysics
    80. JENNINGS M; SWEETLAND H; SMITH CAD; WOLF CR; LENNARD MS; TUCKER GT; WOODS HF; ROGERS K
      LACK OF RELATIONSHIPS BETWEEN THE DEBRISOQUINE (CYP2D6) AND MEPHENYTION (CYP2C19) OXIDATION POLYMORPHISMS AND SUSCEPTIBILITY TO BREAST-CANCER

      Breast
    81. STUBBINS MJ; HARRIES LW; SMITH G; TARBIT MH; WOLF CR
      GENETIC-ANALYSIS OF THE HUMAN CYTOCHROME-P450 CYP2C9 LOCUS

      Pharmacogenetics
    82. DALY AK; BROCKMOLLER J; BROLY F; EICHELBAUM M; EVANS WE; GONZALEZ FJ; HUANG JD; IDLE JR; INGELMANSUNDBERG M; ISHIZAKI T; JACQZAIGRAIN E; MEYER UA; NEBERT DW; STEEN VM; WOLF CR; ZANGER UM
      NOMENCLATURE FOR HUMAN CYP2D6 ALLELES

      Pharmacogenetics
    83. RANE A; LIU ZR; LEVOL R; BJELFMAN C; THYR C; ERICSON H; HANSSON T; HENDERSON C; WOLF CR
      DIFFERENTIAL-EFFECTS OF NEUROLEPTIC AGENTS ON HEPATIC CYTOCHROME-P-450 ISOZYMES IN THE MALE-RAT

      Biochimica et biophysica acta (G). General subjects
    84. ELLIS SW; ROWLAND K; ACKLAND MJ; REKKA E; SIMULA AP; LENNARD MS; WOLF CR; TUCKER GT
      INFLUENCE OF AMINO-ACID RESIDUE-374 OF CYTOCHROME-P-450 2D6 (CYP2D6) ON THE REGIO-SELECTIVE AND ENANTIO-SELECTIVE METABOLISM OF METOPROLOL

      Biochemical journal
    85. FRIEDBERG T; WOLF CR
      RECOMBINANT-DNA TECHNOLOGY AS AN INVESTIGATIVE TOOL IN DRUG-METABOLISM RESEARCH

      Advanced drug delivery reviews
    86. VALLIS KA; WOLF CR
      RELATIONSHIP BETWEEN THE ADAPTIVE RESPONSE TO OXIDANTS AND STABLE MENADIONE-RESISTANCE IN CHINESE-HAMSTER OVARY CELL-LINES

      Carcinogenesis
    87. CAMPBELL SJ; CARLOTTI F; HALL PA; CLARK AJ; WOLF CR
      REGULATION OF THE CYP1A1 PROMOTER IN TRANSGENIC MICE - AN EXQUISITELYSENSITIVE ON-OFF SYSTEM FOR CELL-SPECIFIC GENE-REGULATION

      Journal of Cell Science
    88. CAIRNS W; SMITH CAD; MCLAREN AW; WOLF CR
      CHARACTERIZATION OF THE HUMAN CYTOCHROME P4502D6 PROMOTER - A POTENTIAL ROLE FOR ANTAGONISTIC INTERACTIONS BETWEEN MEMBERS OF THE NUCLEAR RECEPTOR FAMILY

      The Journal of biological chemistry
    89. MOFFAT GJ; MCLAREN AW; WOLF CR
      FUNCTIONAL-CHARACTERIZATION OF THE TRANSCRIPTION SILENCER ELEMENT LOCATED WITHIN THE HUMAN PI-CLASS GLUTATHIONE-S-TRANSFERASE PROMOTER

      The Journal of biological chemistry
    90. MOFFAT GJ; MCLAREN AW; WOLF CR
      SP1-MEDIATED TRANSCRIPTIONAL ACTIVATION OF THE HUMAN-PI-CLASS GLUTATHIONE-S-TRANSFERASE PROMOTER

      The Journal of biological chemistry
    91. BLAKE JAR; PRITCHARD M; DING SH; SMITH GCM; BURCHELL B; WOLF CR; FRIEDBERG T
      COEXPRESSION OF A HUMAN P450 (CYP3A4) AND P450 REDUCTASE GENERATES A HIGHLY FUNCTIONAL MONOOXYGENASE SYSTEM IN ESCHERICHIA-COLI

      FEBS letters
    92. HENDERSON CJ; BACON EJ; SMITH AG; WOLF CR
      DELETION OF MOUSE GLUTATHIONE-S-TRANSFERASE-PI FROM THE MOUSE GENOME BY HOMOLOGOUS RECOMBINATION

      British Journal of Pharmacology
    93. BANDERA M; WOLF CR; BURCHELL B; FRIEDBERG T
      FUNCTIONAL COEXPRESSION OF CYP2D6 AND CYP3A4 WITH RAT NADPH-CYTOCHROME P450 REDUCTASE IN SACCHAROMYCES-CEREVISIAE

      British Journal of Pharmacology
    94. PEDDIE CM; COLLINS AR; WOLF CR; BOWEN DT
      DNA-DAMAGE IN FRESHLY ISOLATED BONE-MARROW CD34+ CELLS ASSOCIATED WITH OXIDATIVE STRESS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

      Blood
    95. HUME R; BURCHELL A; ALLAN BB; WOLF CR; KELLY RW; HALLAS A; BURCHELL B
      THE ONTOGENY OF KEY ENDOPLASMIC-RETICULUM PROTEINS IN HUMAN EMBRYONICAND FETAL RED-BLOOD-CELLS

      Blood
    96. MODI S; PAINE MJ; SUTCLIFFE MJ; LIAN LY; PRIMROSE WU; WOLF CR; ROBERTS GCK
      A MODEL FOR HUMAN CYTOCHROME-P-450 2D6 BASED ON HOMOLOGY MODELING ANDNMR-STUDIES OF SUBSTRATE-BINDING

      Biochemistry
    97. BORLAK JT; SCOTT A; HENDERSON CJ; JENKE HJ; WOLF CR
      TRANSFER OF PCBS VIA LACTATION SIMULTANEOUSLY INDUCES THE EXPRESSION OF P450 ISOENZYMES AND THE PROTOONCOGENES C-HA-RAS AND C-RAF IN NEONATES

      Biochemical pharmacology
    98. MACDONALD IDG; SMITH GCM; WOLF CR; SMITH WE
      OBSERVATION OF STRUCTURAL VARIATION AND SPIN-STATE CONVERSION OF CYTOCHROME-P450 CYP2B4 ON BINDING OF STERICALLY DIFFERENT SUBSTRATES

      Biochemical and biophysical research communications
    99. MACKMAN R; TSCHIRRETGUTH RA; SMITH G; HAYHURST GP; ELLIS SW; LENNARD RS; TUCKER GT; WOLF CR; DEMONTELLANO PRO
      ACTIVE-SITE TOPOLOGIES OF HUMAN CYP2D6 AND ITS ASPARTATE-301-]GLUTAMATE, ASPARAGINE, AND GLYCINE MUTANTS

      Archives of biochemistry and biophysics
    100. PAINE MJI; GILHAM D; ROBERTS GCK; WOLF CR
      FUNCTIONAL HIGH-LEVEL EXPRESSION OF CYTOCHROME-P450 CYP2D6 USING BACULOVIRAL EXPRESSION SYSTEMS

      Archives of biochemistry and biophysics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/02/20 alle ore 10:49:08